MS drug during pregnancy: what happens to Baby's defenses?
NCT ID NCT07149662
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 31 times
Summary
This observational study follows 111 children born to women with multiple sclerosis who received rituximab or similar drugs before or during pregnancy. Researchers want to see if the drug affects the baby's immune cells, increases infections, or weakens vaccine responses in the first year of life. Mothers provide extra blood samples during pregnancy, and babies give one blood sample after birth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Academic specialist center, Center for Neurology
Stockholm, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.